Dietary compounds galangin and myricetin suppress ovarian cancer cell angiogenesis

Journal of Functional Foods

Volumn 15, Issue , 2015, Pages 464-475

  Huang, Haizhi ^a,b   Chen, Allen Y ^c   Rojanasakul, Yon ^c   Ye, Xingqian ^a   Rankin, Gary O ^d   Chen, Yi Charlie ^b  

^a ZHEJIANG UNIVERSITY   (China)

^b Alderson Broaddus College   (United States)

^c WEST VIRGINIA UNIVERSITY   (United States)

^d MARSHALL UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angiogenesis; Galangin; Myricetin; Ovarian cancer; P21

Indexed keywords

EID: 84929241488     PISSN: 17564646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jff.2015.03.051     Document Type: Article

References (51)

1. Alvarez A.A., Krigman H.R., Whitaker R.S., Dodge R.K., Rodriguez G.C. The prognostic significance of angiogenesis in epithelial ovarian carcinoma. Clinical Cancer Research 1999, 5(3):587-591.
2. Basli A., Soulet S., Chaher N., Merillon J.M., Chibane M., Monti J.P., Richard T. Wine polyphenols: Potential agents in neuroprotection. Oxidative Medicine and Cellular Longevity 2012, 2012:805762.
3. Bertl E., Bartsch H., Gerhauser C. Inhibition of angiogenesis and endothelial cell functions are novel sulforaphane-mediated mechanisms in chemoprevention. Molecular Cancer Therapeutics 2006, 5(3):575-585.
4. Bian C.X., Shi Z., Meng Q., Jiang Y., Liu L.Z., Jiang B.H. P70S6K 1 regulation of angiogenesis through VEGF and HIF-1alpha expression. Biochemical and Biophysical Research Communications 2010, 398(3):395-399.
5. Birbrair A., Zhang T., Wang Z.M., Messi M.L., Olson J.D., Mintz A., Delbono O. Type-2 pericytes participate in normal and tumoral angiogenesis. American Journal of Physiology. Cell Physiology 2014, 307(1):C25-C38.
6. Blancher C., Moore J.W., Robertson N., Harris A.L. Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3'-kinase/Akt signaling pathway. Cancer Research 2001, 61(19):7349-7355.
7. Chang H., Mi M.T., Gu Y.Y., Yuan J.L., Ling W.H., Lin H. Effects of flavonoids with different structures on proliferation of leukemia cell line HL-60]. Ai Zheng 2007, 26(12):1309-1314.
8. Chen D., Li M., Luo J., Gu W. Direct interactions between HIF-1 alpha and Mdm2 modulate p53 function. Journal of Biological Chemistry 2003, 278(16):13595-13598.
9. Chen J., Somanath P.R., Razorenova O., Chen W.S., Hay N., Bornstein P., Byzova T.V. Akt1 regulates pathological angiogenesis, vascular maturation and permeability in vivo. Nature Medicine 2005, 11(11):1188-1196.
10. Cho Y.S., Bae J.M., Chun Y.S., Chung J.H., Jeon Y.K., Kim I.S., Kim M.S., Park J.W. HIF-1alpha controls keratinocyte proliferation by up-regulating p21(WAF1/Cip1). Biochimica et Biophysica Acta 2008, 1783(2):323-333.
11. Chung J., Grammer T.C., Lemon K.P., Kazlauskas A., Blenis J. PDGF- and insulin-dependent pp70S6k activation mediated by phosphatidylinositol-3-OH kinase. Nature 1994, 370(6484):71-75.
12. Darcy K.M., Brady W.E., McBroom J.W., Bell J.G., Young R.C., McGuire W.P., Linnoila R.I., Hendricks D., Bonome T., Farley J.H. Associations between p53 overexpression and multiple measures of clinical outcome in high-risk, early stage or suboptimally-resected, advanced stage epithelial ovarian cancers: A Gynecologic Oncology Group study. Gynecologic Oncology 2008, 111(3):487-495. Gynecologic Oncology, G.
13. Duyndam M.C., Hilhorst M.C., Schluper H.M., Verheul H.M., van Diest P.J., Kraal G., Pinedo H.M., Boven E. Vascular endothelial growth factor-165 overexpression stimulates angiogenesis and induces cyst formation and macrophage infiltration in human ovarian cancer xenografts. American Journal of Pathology 2002, 160(2):537-548.
14. Farhang G.M., Goossens S., Haigh J.J. The p53 family and VEGF regulation: "It's complicated". Cell Cycle (Georgetown, Tex.) 2013, 12(9):1331-1332.
15. Farhang G.M., Goossens S., Nittner D., Bisteau X., Bartunkova S., Zwolinska A., Hulpiau P., Haigh K., Haenebalcke L., Drogat B., Jochemsen A., Roger P.P., Marine J.C., Haigh J.J. p53 promotes VEGF expression and angiogenesis in the absence of an intact p21-Rb pathway. Cell Death and Differentiation 2013, 20(7):888-897.
16. Forsythe J.A., Jiang B.H., Iyer N.V., Agani F., Leung S.W., Koos R.D., Semenza G.L. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Molecular and Cellular Biology 1996, 16(9):4604-4613.
17. Fotsis T., Pepper M., Adlercreutz H., Fleischmann G., Hase T., Montesano R., Schweigerer L. Genistein, a dietary-derived inhibitor of in vitro angiogenesis. Proceedings of the National Academy of Sciences of the United States of America 1993, 90(7):2690-2694.
18. Gartel A.L., Radhakrishnan S.K. Lost in transcription: p21 repression, mechanisms, and consequences. Cancer Research 2005, 65(10):3980-3985.
19. Gates M.A., Vitonis A.F., Tworoger S.S., Rosner B., Titus-Ernstoff L., Hankinson S.E., Cramer D.W. Flavonoid intake and ovarian cancer risk in a population-based case-control study. International Journal of Cancer 2009, 124(8):1918-1925.
20. Glade-Bender J., Kandel J.J., Yamashiro D.J. VEGF blocking therapy in the treatment of cancer. Expert Opinion on Biological Therapy 2003, 3(2):263-276.
21. He M., Wang Q.Y., Yin Q.Q., Tang J., Lu Y., Zhou C.X., Duan C.W., Hong D.L., Tanaka T., Chen G.Q., Zhao Q. HIF-1alpha downregulates miR-17/20a directly targeting p21 and STAT3: A role in myeloid leukemic cell differentiation. Cell Death and Differentiation 2013, 20(3):408-418.
22. Hefler L.A., Mustea A., Konsgen D., Concin N., Tanner B., Strick R., Heinze G., Grimm C., Schuster E., Tempfer C., Reinthaller A., Zeillinger R. Vascular endothelial growth factor gene polymorphisms are associated with prognosis in ovarian cancer. Clinical Cancer Research 2007, 13(3):898-901.
23. Ho J.S., Ma W., Mao D.Y., Benchimol S. p53-Dependent transcriptional repression of c-myc is required for G1 cell cycle arrest. Molecular and Cellular Biology 2005, 25(17):7423-7431.
24. Jiang B.H., Liu L.Z. AKT signaling in regulating angiogenesis. Current Cancer Drug Targets 2008, 8(1):19-26.
25. Jung S.K., Lee K.W., Byun S., Lee E.J., Kim J.E., Bode A.M., Dong Z., Lee H.J. Myricetin inhibits UVB-induced angiogenesis by regulating PI-3 kinase in vivo. Carcinogenesis 2010, 31(5):911-917.
26. Kandasamy N., Ashokkumar N. Myricetin modulates streptozotocin-cadmium induced oxidative stress in long term experimental diabetic nephrotoxic rats. Journal of Functional Foods 2013, 5(3):1466-1477.
27. Kim D.A., Jeon Y.K., Nam M.J. Galangin induces apoptosis in gastric cancer cells via regulation of ubiquitin carboxy-terminal hydrolase isozyme L1 and glutathione S-transferase P. Food and Chemical Toxicology 2012, 50(3-4):684-688.
28. Kim J.D., Liu L., Guo W., Meydani M. Chemical structure of flavonols in relation to modulation of angiogenesis and immune-endothelial cell adhesion. Journal of Nutritional Biochemistry 2006, 17(3):165-176.
29. Kim M.E., Ha T.K., Yoon J.H., Lee J.S. Myricetin induces cell death of human colon cancer cells via BAX/BCL2-dependent pathway. Anticancer Research 2014, 34(2):701-706.
30. Li S., Pan M.-H., Lo C.-Y., Tan D., Wang Y., Shahidi F., Ho C.-T. Chemistry and health effects of polymethoxyflavones and hydroxylated polymethoxyflavones. Journal of Functional Foods 2009, 1(1):2-12.
31. Li S., Wang H., Guo L., Zhao H., Ho C.-T. Chemistry and bioactivity of nobiletin and its metabolites. Journal of Functional Foods 2014, 6:2-10.
32. Luo H., Rankin G.O., Juliano N., Jiang B.H., Chen Y.C. Kaempferol inhibits VEGF expression and in vitro angiogenesis through a novel ERK-NFkappaB-cMyc-p21 pathway. Food Chemistry 2012, 130(2):321-328.
33. Luo H., Rankin G.O., Liu L., Daddysman M.K., Jiang B.H., Chen Y.C. Kaempferol inhibits angiogenesis and VEGF expression through both HIF dependent and independent pathways in human ovarian cancer cells. Nutrition and Cancer-an International Journal 2009, 61(4):554-563.
34. Ma N., Lai C.-S., Chung C.-H., Yang J.-M., Hsu K.-C., Chen C.-Y., Chung T.-S., Li S., Ho C.-T., Pan M.-H. 5-Demethyltangeretin is more potent than tangeretin in inhibiting dimethylbenz(a)anthracene (DMBA)/12-O-tetradecanoylphorbol-13-acetate (TPA)-induced skin tumorigenesis. Journal of Functional Foods 2014, 11:528-537.
35. Park K.I., Park H.S., Kim M.K., Hong G.E., Nagappan A., Lee H.J., Yumnam S., Lee W.S., Won C.K., Shin S.C., Kim G.S. Flavonoids identified from Korean Citrus aurantium L. inhibit non-small cell lung cancer growth in vivo and in vitro. Journal of Functional Foods 2014, 7:287-297.
36. Phillips P.A., Sangwan V., Borja-Cacho D., Dudeja V., Vickers S.M., Saluja A.K. Myricetin induces pancreatic cancer cell death via the induction of apoptosis and inhibition of the phosphatidylinositol 3-kinase (PI3K) signaling pathway. Cancer Letters 2011, 308(2):181-188.
37. Ravi R., Mookerjee B., Bhujwalla Z.M., Sutter C.H., Artemov D., Zeng Q., Dillehay L.E., Madan A., Semenza G.L., Bedi A. Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha. Genes and Development 2000, 14(1):34-44.
38. Ross J.A., Kasum C.M. Dietary flavonoids: Bioavailability, metabolic effects, and safety. Annual Review of Nutrition 2002, 22:19-34.
39. Sanchez-Munoz A., Perez-Ruiz E., Mendiola F.C., Alba C.E., Gonzalez-Martin A. Current status of anti-angiogenic agents in the treatment of ovarian carcinoma. Clinical and Translational Oncology 2009, 11(9):589-595.
40. Somanath P.R., Razorenova O.V., Chen J., Byzova T.V. Akt1 in endothelial cell and angiogenesis. Cell Cycle (Georgetown, Tex.) 2006, 5(5):512-518.
41. Takei Y., Saga Y., Mizukami H., Takayama T., Ohwada M., Ozawa K., Suzuki M. Overexpression of PTEN in ovarian cancer cells suppresses i.p. dissemination and extends survival in mice. Molecular Cancer Therapeutics 2008, 7(3):704-711.
42. Tsai S.H., Liang Y.C., Lin-Shiau S.Y., Lin J.K. Suppression of TNFalpha-mediated NFkappaB activity by myricetin and other flavonoids through downregulating the activity of IKK in ECV304 cells. Journal of Cellular Biochemistry 1999, 74(4):606-615.
43. van Uden P., Kenneth N.S., Rocha S. Regulation of hypoxia-inducible factor-1alpha by NF-kappaB. Biochemical Journal 2008, 412(3):477-484.
44. Yu E.A., Kim G.S., Jeong S.W., Park S., Lee S.J., Kim J.H., Lee W.S., Bark K.M., Jin J.S., Shin S.C. Flavonoid profile and biological activity of Korean citrus varieties (II): Pyunkyul (Citrus tangerina Hort. ex Tanaka) and overall contribution of its flavonoids to antioxidant effect. Journal of Functional Foods 2014, 6:637-642.
45. Zang W., Wang T., Wang Y., Li M., Xuan X., Ma Y., Du Y., Liu K., Dong Z., Zhao G. Myricetin exerts anti-proliferative, anti-invasive, and pro-apoptotic effects on esophageal carcinoma EC9706 and KYSE30 cells via RSK2. Tumour Biology: The Journal of the International Society for Oncodevelopmental Biology and Medicine 2014, 35(12):12583-12592.
46. Zhang H., Li N., Wu J., Su L., Chen X., Lin B., Luo H. Galangin inhibits proliferation of HepG2 cells by activating AMPK via increasing the AMP/TAN ratio in a LKB1-independent manner. European Journal of Pharmacology 2013, 718(1-3):235-244.
47. Zhang H.T., Luo H., Wu J., Lan L.B., Fan D.H., Zhu K.D., Chen X.Y., Wen M., Liu H.M. Galangin induces apoptosis of hepatocellular carcinoma cells via the mitochondrial pathway. World Journal of Gastroenterology 2010, 16(27):3377-3384.
48. Zhang J.K., Wu Y.P., Zhao X.Y., Luo F.L., Li X., Zhu H., Sun C.D., Chen K.S. Chemopreventive effect of flavonoids from Ougan (Citrus reticulata cv. Suavissima) fruit against cancer cell proliferation and migration. Journal of Functional Foods 2014, 10:511-519.
49. Zhang W., Lan Y., Huang Q., Hua Z. Galangin induces B16F10 melanoma cell apoptosis via mitochondrial pathway and sustained activation of p38 MAPK. Cytotechnology 2013, 65(3):447-455.
50. Zhang X.H., Chen S.Y., Tang L., Shen Y.Z., Luo L., Xu C.W., Liu Q., Li D. Myricetin induces apoptosis in HepG2 cells through Akt/p70S6K/bad signaling and mitochondrial apoptotic pathway. Anti-cancer Agents in Medicinal Chemistry 2013, 13(10):1575-1581.
51. Zivkovic J., Barreira J.C.M., Stojkovic D., Cebovic T., Santos-Buelga C., Maksimovic Z., Ferreira I.C.F.R. Phenolic profile, antibacterial, antimutagenic and antitumour evaluation of Veronica urticifolia Jacq. Journal of Functional Foods 2014, 9:192-201.